Literature DB >> 9442945

Production of virulence-related proteins by Canadian strains of Streptococcus suis capsular type 2.

M Gottschalk1, A Lebrun, H Wisselink, J D Dubreuil, H Smith, U Vecht.   

Abstract

The production of muramidase-released protein (MRP), extracellular protein factor (EF) and hemolysin (suilysin) by 101 Canadian field strains of Streptococcus suis capsular type 2 is described. Most strains (72%) isolated from diseased pigs were MRP-EF- and only 1 strain was MRP+EF+. This strain was also the only 1 to produce the hemolysin. Thirteen strains (15%) were MRP+ EF- and only 3 strains were MRP* EF-. All the strains isolated from clinically healthy pigs as well as a bovine and 2 human isolates had a MRP-EF- phenotype. In addition, 7 strains (8%) had a MRPS phenotype, which had so far been described for S. suis capsular type 1. In conclusion, most Canadian field isolates of S. suis capsular type 2 tested in this study do not produce the virulence-related proteins described so far for this bacterial pathogen.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9442945      PMCID: PMC1189447     

Source DB:  PubMed          Journal:  Can J Vet Res        ISSN: 0830-9000            Impact factor:   1.310


  20 in total

1.  Description of six new capsular types (29-34) of Streptococcus suis.

Authors:  R Higgins; M Gottschalk; M Boudreau; A Lebrun; J Henrichsen
Journal:  J Vet Diagn Invest       Date:  1995-07       Impact factor: 1.279

2.  Clonal analysis and virulence of Australian isolates of Streptococcus suis type 2.

Authors:  C G Mwaniki; I D Robertson; D J Trott; R F Atyeo; B J Lee; D J Hampson
Journal:  Epidemiol Infect       Date:  1994-10       Impact factor: 2.451

3.  Meningitis caused by Streptococcus suis in humans.

Authors:  J P Arends; H C Zanen
Journal:  Rev Infect Dis       Date:  1988 Jan-Feb

4.  Antimicrobial resistance patterns and plasmid profiles of Streptococcus suis isolates.

Authors:  M Cantin; J Harel; R Higgins; M Gottschalk
Journal:  J Vet Diagn Invest       Date:  1992-04       Impact factor: 1.279

5.  Identification, purification, and characterization of a thiol-activated hemolysin (suilysin) of Streptococcus suis.

Authors:  A A Jacobs; P L Loeffen; A J van den Berg; P K Storm
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

6.  Discrimination between virulent and nonvirulent Streptococcus suis type 2 strains by enzyme-linked immunosorbent assay.

Authors:  U Vecht; H J Wisselink; J Anakotta; H E Smith
Journal:  Vet Microbiol       Date:  1993-01       Impact factor: 3.293

7.  Characterization of Streptococcus suis capsular type 2 haemolysin.

Authors:  M G Gottschalk; S Lacouture; J D Dubreuil
Journal:  Microbiology       Date:  1995-01       Impact factor: 2.777

8.  Discrimination of virulent and avirulent Streptococcus suis capsular type 2 isolates from different geographical origins.

Authors:  S Quessy; J D Dubreuil; M Caya; R Higgins
Journal:  Infect Immun       Date:  1995-05       Impact factor: 3.441

9.  Identification of two proteins associated with virulence of Streptococcus suis type 2.

Authors:  U Vecht; H J Wisselink; M L Jellema; H E Smith
Journal:  Infect Immun       Date:  1991-09       Impact factor: 3.441

10.  Distribution of Streptococcus suis capsular types in Quebec and western Canada.

Authors:  R Higgins; M Gottschalk; M Beaudoin; S A Rawluk
Journal:  Can Vet J       Date:  1992-01       Impact factor: 1.008

View more
  36 in total

Review 1.  Agents of the "suis-ide diseases" of swine: Actinobacillus suis, Haemophilus parasuis, and Streptococcus suis.

Authors:  J I MacInnes; R Desrosiers
Journal:  Can J Vet Res       Date:  1999-04       Impact factor: 1.310

2.  Identification of a surface protein of Streptococcus suis and evaluation of its immunogenic and protective capacity in pigs.

Authors:  Yuanyi Li; Gabriela Martinez; Marcelo Gottschalk; Sonia Lacouture; Philip Willson; J Daniel Dubreuil; Mario Jacques; Josee Harel
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

3.  Identification of the gene encoding a 38-kilodalton immunogenic and protective antigen of Streptococcus suis.

Authors:  Ogi Okwumabua; Sharmila Chinnapapakkagari
Journal:  Clin Diagn Lab Immunol       Date:  2005-04

4.  Heat-killed Streptococcus suis capsular type 2 strains stimulate tumor necrosis factor alpha and interleukin-6 production by murine macrophages.

Authors:  M Segura; J Stankova; M Gottschalk
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

5.  Relatedness of Streptococcus suis isolates of various serotypes and clinical backgrounds as evaluated by macrorestriction analysis and expression of potential virulence traits.

Authors:  A Allgaier; R Goethe; H J Wisselink; H E Smith; P Valentin-Weigand
Journal:  J Clin Microbiol       Date:  2001-02       Impact factor: 5.948

6.  Genetic diversity of Streptococcus suis serotypes 2 and 1/2 isolates recovered from carrier pigs in closed herds.

Authors:  Gabriela Martinez; Josée Harel; Sonia Lacouture; Marcelo Gottschalk
Journal:  Can J Vet Res       Date:  2002-10       Impact factor: 1.310

7.  Genetic diversity of Streptococcus suis strains isolated from pigs and humans as revealed by pulsed-field gel electrophoresis.

Authors:  Florence Berthelot-Hérault; Corinne Marois; Marcelo Gottschalk; Marylène Kobisch
Journal:  J Clin Microbiol       Date:  2002-02       Impact factor: 5.948

8.  Characterization of Streptococcus suis isolates from slaughter swine.

Authors:  Kaicheng Wang; Wei Zhang; Xiaocheng Li; Chengping Lu; Jiming Chen; Weixing Fan; Baoxu Huang
Journal:  Curr Microbiol       Date:  2012-12-07       Impact factor: 2.188

9.  Invasion of porcine brain microvascular endothelial cells by Streptococcus suis serotype 2.

Authors:  Ghyslaine Vanier; Mariela Segura; Peter Friedl; Sonia Lacouture; Marcelo Gottschalk
Journal:  Infect Immun       Date:  2004-03       Impact factor: 3.441

10.  Streptococcus suis in humans, Thailand.

Authors:  Daisuke Takamatsu; Korawan Wongsawan; Makoto Osaki; Hiroto Nishino; Tomono Ishiji; Prasit Tharavichitkul; Banyong Khantawa; Achara Fongcom; Shinji Takai; Tsutomu Sekizaki
Journal:  Emerg Infect Dis       Date:  2008-01       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.